Look Out for Mix-Ups With GLP-1 Agonists for Diabetes

August 2019

You'll get more Rxs for the injectable diabetes meds Trulicity (dulaglutide), Ozempic (semaglutide), and Victoza (liraglutide).

It's because these three "GLP-1 agonists" lower cardiovascular (CV) risk in some patients with type 2 diabetes.

Other GLP-1 agonists...Adlyxin, Bydureon...are CV neutral.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medication Errors Prevent Mishaps With Meds That Patients Need to Mix Before Use
Antimalarials Expect Some Travelers to Get Arakoda for Malaria Prevention
Compounding Be Ready for Non-Sterile Compounding Changes With USP 795 Updates
Insulin Use Strategies to Help Patients Afford Insulin
Photosensitivity Watch for Patients on Meds That Make Them Prone to Sun Sensitivity
Opioids Don't Think of Tramadol as a "Safer" Opioid
Diabetes Look Out for Mix-Ups With GLP-1 Agonists for Diabetes
Lupus Know How Meds for Lupus Stack Up
Pregnancy Stay Alert for OTC GI Meds That Pose Risks in Pregnancy
Patient Safety Get the Facts About Stem Cells